We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 30, 2020

Effect of Tocilizumab in Patients Hospitalized With COVID-19 Pneumonia

JAMA Internal Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Internal Medicine
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial
JAMA Intern Med 2020 Oct 20;[EPub Ahead of Print], C Salvarani, G Dolci, M Massari, DF Merlo, S Cavuto, L Savoldi, P Bruzzi, F Boni, L Braglia, C Turrà, PF Ballerini, R Sciascia, L Zammarchi, O Para, PG Scotton, WO Inojosa, V Ravagnani, ND Salerno, PP Sainaghi, A Brignone, M Codeluppi, E Teopompi, M Milesi, P Bertomoro, N Claudio, M Salio, M Falcone, G Cenderello, L Donghi, V Del Bono, PL Colombelli, A Angheben, A Passaro, G Secondo, R Pascale, I Piazza, N Facciolongo, M Costantini, RCT-TCZ-COVID-19 Study Group

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading